Alpha1-antitrypsin as a risk for infant and adult respiratory outcomes in a national birth cohort

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 5, 2004, Pages 559-564

  Wadsworth, Michael E J ^a   Vinall, Lynne E ^b   Jones, Abigail L ^b   Hardy, Rebecca J ^b   Whitehouse, David B ^b   Butterworth, Suzanne L ^b   Hilder, Warren S ^b   Lovegrove, Jennifer U ^b   Swallow, Dallas M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; DNA; SERPINA1 PROTEIN, HUMAN;

ADULT; ADULT DISEASE; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENOTYPE; HUMAN; INFANT DISEASE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SERPINA1 GENE; SOCIOECONOMICS; ALLELE; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; PHENOTYPE; RESPIRATORY TRACT INFECTION; RISK; SPIROMETRY; TIME;

ADULT; ALLELES; ALPHA 1-ANTITRYPSIN; COHORT STUDIES; DNA; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RESPIRATORY TRACT INFECTIONS; RISK; SPIROMETRY; TIME FACTORS;

EID: 7744223457     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0027OC     Document Type: Article

References (31)

1. Barnes, P. J. 1999. Genetics and pulmonary medicine: molecular genetics of chronic obstructive pulmonary disease. Thorax 54:245-252.
2. Kalsheker, N., S. Morley, and K. Morgan. 2002. Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem. Soc. Trans. 30:93-98.
3. Lomas, D. A., and R. Mahadeva. 2002. Alpha 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest. 110:1585-1590.
4. Brantly, M. L., J. T. Wittes, C. F. Vogelmeier, R. C. Hubbard, G. A. Fells, and R. G. Crystal. 1991. Use of a highly purified alpha1-antitrypsin standard to establish ranges for the common, normal and deficient alpha1-antitrypsin phenotypes. Chest 100:703-708.
5. Dabbagh, K., G. J. Laurent, A. Shock, P. Leoni, J. Papakrivopoulou, and R. C. Chambers. 2001. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J. Cell. Physiol. 186:73-81.
6. Sandford, A. J., T. Chagani, T. D. Weir, J. E. Connett, N. R. Anthonisen, and P. D. Pare. 2001. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 163:469-473.
7. Piitulainen, E., and T. Sveger. 2002. Respiratory symptoms and lung function in young adults with severe alpha (1)-antitrypsin deficiency (PiZZ). Thorax 7:705-708.
8. Eden, E., J. Hammel, F. N. Rouhani, M. L. Brantly, A. F. Barker, A. S. Buist, R. J. Fallat, J. K. Stoller, R. G. Crystal, and G. M. Turino. 2003. Asthma features in severe alpha1-antitrypsin deficiency. Chest 123:765-771.
9. Silva, G. E., D. L. Sherrill, S. Guerra, and R. A. Barbee. 2003. A longitudinal study of alpha1-antitrypsin phenotype and decline in FEV1 in a community population. Chest 123:1435-1440.
10. Dahl, M., A. Tybjaeg-Hansen, P. Lange, J. Vetsbo, and B. Nordestgaard. 2002. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study in the general population. Ann. Intern. Med. 136:270-279.
11. Alvarez-Granda, L., M. J. Cabero-Perez, A. Bustamente-Ruir, D. Gonzalez-Lamuno, M. Delgado-Rodriguez, and M. Garcia-Fuentes. 1997. PI SZ phenotype in chronic obstructive pulmonary disease. Thorax 52:659-661.
12. Lieberman, J., B. Winter, and A. Sastre. 1986. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89:370-373.
13. Bartmann, K., M. Fooke-Achterrath, G. Koch, I. Nagy, I. Schutz, E. Weis, and M. Zierski. 1985. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur. J. Respir. Dis. 66:284-296.
14. Cox, D. W., V. H. Hoeppner, and H. Levison. 1976. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. Am. Rev. Respir. Dis. 113:601-606.
15. Seersholm, N., J. T. Wilcke, A. Kok-Jensen, and A. Dirksen. 2000. Risk of hospital admission for obstructive pulmonary disease in α1-antityrpsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 161:81-84.
16. Bruce, R. M., B. H. Cohen, E. L. Diamond, R. J. Fallat, R. J. Knudson, M. D. Lebowtiz, C. Mittman, C. D. Patterson, and M. S. Tockman. 1984. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am. Rev. Respir. Dis. 130:386-390.
17. Morse, J. O., M. D. Lebowitz, R. J. Knudson, and B. Burrows. 1977. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N. Engl. J. Med. 296:1190-1194.
18. Eriksson, S., S. E. Lindell, and R. Wiberg. 1985. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. Eur. J. Respir. Dis. 67:279-285.
19. Sandford, A. J., T. D. Weir, J. J. Spinelli, and P. D. Pare. 1999. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 20:287-291.
20. Kalsheker, N. A., G. L. Watkins, S. Hill, K. Morgan, R. A. Stockley, and R. B. Fick. 1990. Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis. Markers 8:151-157.
21. Poller, W., C. Meisen, and K. Olek. 1990. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 20:1-7.
22. Sandford, A. J., J. J. Spinelli, T. D. Weir, and P. D. Pare. 1997. Mutation in the 3′ region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. J. Med. Genet. 34:874-875.
23. Mann, S. L., M. E. J. Wadsworth, and J. R. T. Colley. 1992. Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring. J. Epidemiol. Community Health 46:286-292.
24. Shaheen, S. 1997. The beginnings of chronic airflow obstruction. In M.G. Marmot and M.E.J. Wadsworth, editors. Fetal and Early Childhood Environment. Br. Med. Bull. 53:58-70.
25. Barker, D. J. P. 1998. Mothers, Babies, and Disease in Later Life. British Medical Journal Publishing, London.
26. Wadsworth, M. E. J., S. L. Butterworth, R. J. Hardy, D. J. L. Kuh, M. Richards, C. Langenberg, W. S. Hilder, and M. Connor. 2003. Response and validity in a long-term prospective study. Soc. Sci. Med. 57:2193-2205.
27. Whitehouse, D. B., J. U. Lovegrove, and D. A. Hopkinson. 1989. Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Clin. Chim. Acta 179:109-115.
28. Pauwels, R. A., A. S. Buist, P. M. Calverley, C. R. Jenkins, and S. S. Hurd. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163:1256-1276.
29. Falaschetti, E., J. Laiho, P. Primatesta, and S. Purdon. 2004. Prediction equations for normal and low lung function from the Health Survey for England. Eur. Respir. J. 23:456-463.
30. Excoffier, L., and M. Slatkin. 1995. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12:921-927.
31. Von Ehrenstein, O. S., E. von Mutius, E. Maier, T. Hirsch, D. Carr, W. Schaal, A. A. Roscher, B. Olgemoller, T. Nicolai, and S. K. Weiland. 2002. Lung function of school children with low levels of alpha1-antitrypsin and tobacco smoke exposure. Eur. Respir. J. 19:1099-1106.